Insights | Fish & Richardson

Diversity, Equity & Inclusion

Pro Bono & Social Responsibility

Legal Operations

Legal Project Management

Knowledge Management

Legal Technology Services

Patent Litigation

Trademark, Copyright & Media Litigation

Trade Secret Litigation

Standard Essential Patents

Chancery & Corporate Governance

<p><em>Inter Partes </em>Review</p>

Post-Grant Review

<p><em>Ex Parte</em> Reexamination</p>

Supplemental Examination

Patent Prosecution

Strategic Patent Counseling & Opinions

Patent Portfolio Management

Unitary Patent & Unified Patent Court

IP Licensing, Transactions & Agreements

Trademark & Copyright Counseling & Prosecution

Strategic Counseling, Registration & Opinions

Advertising & Marketing

Domain Names & Internet

TTAB Oppositions & Cancellations

Digital Millennium Copyright Act

Transactions & Agreements

Regulatory & Government Affairs

Communications & Spectrum Regulation

Drug & Medical Device Regulation

mHealth & Telemedicine

Privacy & Data Security

Electrical & Computer Technology

Software & Internet

Consumer Electronics

Artificial Intelligence

Digital Media & E-Commerce

Financial, Business & FinTech Services

Telecommunications

Energy & Chemicals

Biotech & Diagnostics

Medical Devices

Pharmaceuticals

Academic Research & Medical Centers

Transportation, Aerospace & Defense

Autonomous Vehicles

Thought Leadership

IP Law Essentials

Post-Grant Annual Reports

Search results

Blog | June 16, 2025

Ingenico v. IOENGINE and the Diminishing Role of Sotera Stipulations

Post-Grant Report | March 05, 2025

2024 Post-Grant Annual Report

Blog | February 24, 2025

Biologics and Biosimilars Landscape 2024: IP, Policy, and Market Developments

Blog | April 05, 2024

Biologics and Biosimilars Landscape 2023: IP, Policy, and Market Developments

Article | March 28, 2024

When Does IPR Estoppel Apply to Product or System Art in District Court?

Post-Grant Report | January 17, 2024

2023 Post-Grant Annual Report

Blog | October 17, 2023

USPTO Issues Proposed Rules on Pre-Issuance Internal Circulation and Review of PTAB Decisions

Blog | April 26, 2023

USPTO Issues Advance Notice of Proposed Rulemaking for PTAB Proceedings

Post-Grant Report | February 28, 2023

2022 Post-Grant Annual Report

Webinar | January 31, 2023

Post-Grant for Practitioners | 2022 Year in Review

Blog | January 17, 2023

Biosimilars 2022 Year in Review

Article | December 22, 2022

A Look Back on a Decade of Practice at the PTAB